All In Biotech

Drug Trial Radar · NCT07454369

Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination

Comparative Bioavailability Study Between Etoricoxib/Betamethasone Tablets 90 mg/0,25 mg From Laboratorios Silanes, SA de CV vs Etoricoxib Tablets 90 mg (Arcoxia®) and Betamethasone Solution 50 mg/100 mL (Celestone® Pediatric) From Laboratorios Schering-Plough SA de CV, Administered Individually or in Combination, in an Open-label, Randomized, Single-dose, 3-period, 6-sequence, 3-treatment Design in Healthy Subjects of Both Genders Under Fasting Conditions

Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

42

Actual

Start

Oct 24, 2022

Primary completion

Nov 25, 2022

Study completion Jan 6, 2023

Sponsor

Sponsor type
Industry
First posted
Mar 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study seeks to evaluate the comparative bioavailability of etoricoxib/betamethasone tablets 90 mg/0.25 mg test drug, administered in fixed combination vs. etoricoxib tablets 90 mg (Arcoxia®) reference drug, and betamethasone solution 50 mg/100 mL (Celestone® Pediatric) reference drug, administered individually, in a single dose, to 42 healthy mexican research subjects of both genders, under fasting conditions.

Conditions

  • Healthy

Interventions

  • A1: Etoricoxib / Betamethasone in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)Drug

    Formula: 90 mg/ 0.25 mg. Pharmaceutical Form: Tablet. Dosage: 1 tablet (90 mg/ 0.25 mg) Administration way: oral

  • A2: Etoricoxib (Arcoxia®, Laboratorios Schering-Plough, S.A. de C.V.)Drug

    A2: Pharmaceutical Form: Tablet Formula: 90 mg Dosage: 1 tablet of 90 mg Administration way: oral

  • A3: Betamethasone (Celestone® Pediatric, Laboratorios Schering-Plough, S.A. de C.V.)Drug

    A3: Pharmaceutical Form: Solution Formula: Each 100 mL of solution contains 50 mg of betamethasone. Dosage: 0.5 mL equivalent to 0.25 mg of betamethasone. Administration way: Oral.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine the Cmax.Time frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.
  2. Determine the AUC 0-tTime frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.
  3. Determine the AUC 0-infTime frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.
  4. Determine the TmaxTime frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.
  5. Determine the KeTime frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.
  6. Determine the T1/2Time frame: Baseline, 0.25, 0.50, 0.75, 1.00, 1.25, 1.50, 2.00, 2.50, 3.00, 4.00, 6.00, 8.00, 12.00, 14.00, 24.00, 36.00, 48.00 and 72.00 hours.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Pharmacology and Toxicology of the Faculty of Medicine of the Universidad Autónoma de Nuevo León

    Monterrey, Nuevo León, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.